“By late next year, things could return to near normal,” Gates, 64, told the Wall Street Journal board of directors.
He added: “We still do not know if these vaccines will work.
“Now the increase in capacity will take time. So the distribution within the United States and between the United States and other countries will be a very major point of contention,” Gates said.
Two COVID-19 vaccines, developed by Phaser / BionTech and AstraZeneca / University of Oxford, top the list of major vaccines in the race for regulatory approval in the West.
The Director-General of the World Health Organization said Tuesday that it is likely that a vaccine against Covid-19 will be ready by the end of the year.
Gates gave $ 36 billion to the Bill & Melinda Gates Foundation, which aims to tackle extreme poverty and poor health care.
Last month, the foundation signed an agreement with 16 pharmaceutical companies that Gates said obliged them to expand manufacturing at an unprecedented speed and to ensure that approved vaccines are widely distributed as soon as possible.